Bristol Myers Squibb Receives European Commission Approval for Opdivo as Second-Line Treatment for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
Gilead Sciences to Present at the 3rd Annual Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020 Biotech Investing
Sixth Wave Teams Up with University of Alberta Researchers in Development of Rapid Synthetic Test for SARS-CoV-2 and Other Viruses Life Science Investing News
Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test Medical Device Investing
Avricore Health's HealthTab Endorsed by Ontario Pharmacists Association for Real-Time COVID-19 Data Reporting in Community Pharmacies Medical Device Investing
Algernon Pharmaceuticals Announces 154 Patients Enrolled in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19 Biotech Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
